Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Liminal’s possible last trading day on NASDAQ
View:
Post by balain on Aug 31, 2022 11:01am

Liminal’s possible last trading day on NASDAQ

Today could be Liminal’s last trading day on the NASDAQ due to their failure to comply with the exchange minimum share price requirement of $1 usd for a minimum of 10 consecutive business days.
They’ve already failed to comply with this, but as per the news release posted below, management said they would do everything they can to regain compliance and keep trading on the exchange. I am not too sure what trick they intend to pull, but they said they would look at all options available to them leading to their last day to comply on 31 August 2022. The clock is ticking…

https://stocks.apple.com/AavaMS1tlQNSZWtTRppU2pw
Comment by stockbuphoon on Aug 31, 2022 12:41pm
It's amazing that it isn't at 5 cents today? Does no one pay attention to these press releases? There will be no liquidity to sell off after they are removed. Thry shut 4050 and sold Ryplazim. What is left? Maybe a new version of 4050 in preclinical trial still years away from revenue or partner deal?  Yet, Pritchard being paid as a $1B company valuation CEO. Incredible. 
Comment by Dibah420 on Sep 01, 2022 5:15pm
balain:  Given the paucity of potential catalysts the only trick left for this pony is another reverse split.  Let's say they do a 4:1 to bring the s/p up to $2.   I give maybe 90 days for the shares to tank down to penny status...and, shortly thereafter,  another delisting notice  Bonne fete du tarvail!
Comment by Damnre on Sep 02, 2022 6:38am
They have 5 months to recover
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities